Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Rheumatoid arthritis disease measurement: a new old idea.

Hobbs KF, Cohen MD.

Rheumatology (Oxford). 2012 Dec;51 Suppl 6:vi21-7. doi: 10.1093/rheumatology/kes282. Review.

PMID:
23221583
2.

Safety, tolerability, and clinical outcomes after intraarticular injection of a recombinant adeno-associated vector containing a tumor necrosis factor antagonist gene: results of a phase 1/2 Study.

Mease PJ, Wei N, Fudman EJ, Kivitz AJ, Schechtman J, Trapp RG, Hobbs KF, Greenwald M, Hou A, Bookbinder SA, Graham GE, Wiesenhutter CW, Willis L, Ruderman EM, Forstot JZ, Maricic MJ, Dao KH, Pritchard CH, Fiske DN, Burch FX, Prupas HM, Anklesaria P, Heald AE.

J Rheumatol. 2010 Apr;37(4):692-703. doi: 10.3899/jrheum.090817. Epub 2009 Dec 23.

PMID:
20032102
3.

Lipodystrophy and metabolic abnormalities in a case of adult dermatomyositis.

Lee LA, Hobbs KF.

J Am Acad Dermatol. 2007 Nov;57(5 Suppl):S85-7.

PMID:
17938031
4.

A retrospective analysis of low-field strength magnetic resonance imaging and the management of patients with rheumatoid arthritis.

Schiff MH, Hobbs KF, Gensler T, Keenan GF.

Curr Med Res Opin. 2007 May;23(5):961-8.

PMID:
17519063
5.

The benefit/risk profile of TNF-blocking agents: findings of a consensus panel.

Hochberg MC, Lebwohl MG, Plevy SE, Hobbs KF, Yocum DE.

Semin Arthritis Rheum. 2005 Jun;34(6):819-36. Review.

PMID:
15942917
6.

Supplemental Content

Loading ...
Support Center